-
公开(公告)号:US20240166610A1
公开(公告)日:2024-05-23
申请号:US18263702
申请日:2022-01-29
发明人: Lingyun WU , Lele ZHAO , Jianjun SUN , Chuang QIAO , Shuhui CHEN
IPC分类号: C07D237/20 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D453/02 , C07D491/107 , C07D519/00
CPC分类号: C07D237/20 , C07D401/12 , C07D401/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D453/02 , C07D491/107 , C07D519/00
摘要: Substituted pyridazine phenol derivatives and a preparation method therefor, specifically relating to a compound as shown in formula (VI) and a pharmaceutically acceptable salt thereof, which can be used as an NLRP3 inhibitor.
-
公开(公告)号:US20240199571A1
公开(公告)日:2024-06-20
申请号:US18549188
申请日:2022-03-04
发明人: Lingyun WU , Zhen ZHAN , Lele ZHAO , Jianjun SUN , Yi QIAN , Shuhui CHEN
IPC分类号: C07D333/22 , A61K31/381 , A61K31/407 , A61K31/438 , A61K31/439 , A61K31/495 , A61K31/551 , C07D403/04 , C07D413/04
CPC分类号: C07D333/22 , A61K31/381 , A61K31/407 , A61K31/438 , A61K31/439 , A61K31/495 , A61K31/551 , C07D403/04 , C07D413/04
摘要: The present invention relates to a thiophene compound and an application thereof. The present invention specifically relates to a compound represented by formula (II) and a pharmaceutically acceptable salt thereof, wherein L1 is —C(═O)— or —C(═O)—NH—; R1 is R1a or aa; ring A is bb or cc; R1a is C1-3 alkyl substituted with 1, 2 or 3 Ra; and R3 is independently H, halogen or C1-3 alkoxy. The compound represented by formula (II) and the pharmaceutically acceptable salt thereof can better inhibit the activity of LSD1, further shows significant inhibitory activity against NCI-H1417 cell proliferation, and has good pharmacokinetic properties (including good oral bioavailability, oral exposure, half-life, and clearance rate, etc.).
-
公开(公告)号:US20240208945A1
公开(公告)日:2024-06-27
申请号:US18550468
申请日:2022-03-24
发明人: Lingyun WU , Tianzi DAI , Lele ZHAO , Jianjun SUN , Yi QIAN , Jian LI , Shuhui CHEN
IPC分类号: C07D403/12 , A61K31/517 , A61K31/519 , A61K31/5377 , A61K31/551 , A61P35/00 , C07D401/12 , C07D405/14 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D491/048 , C07D491/107
CPC分类号: C07D403/12 , A61K31/517 , A61K31/519 , A61K31/5377 , A61K31/551 , A61P35/00 , C07D401/12 , C07D405/14 , C07D413/12 , C07D471/04 , C07D487/04 , C07D487/08 , C07D491/048 , C07D491/107
摘要: Disclosed are 6-carbamate substituted heteroaryl ring derivatives and a preparation method therefor. The present application particularly relates to a compound as shown in formula (II) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20220064126A1
公开(公告)日:2022-03-03
申请号:US17460662
申请日:2021-08-30
发明人: Lingyun WU , Lele ZHAO , Jianjun SUN , Zhen ZHAN , Shuhui CHEN
IPC分类号: C07D231/12 , C07D401/06 , C07D401/04 , C07D401/14 , C07D403/12 , C07D403/06 , C07D471/10 , C07D487/04
摘要: Disclosed are a class of pyrazole compounds and applications thereof in the preparation of a medicament for treating related diseases. Specifically, related are a compound represented by formula (II) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20200345700A1
公开(公告)日:2020-11-05
申请号:US16479602
申请日:2018-01-24
发明人: Lingyun WU , Li ZHANG , Lele ZHAO , Jianjun SUN , Zhaoguo CHEN , Jian Ll , Shuhui CHEN
IPC分类号: A61K31/4245 , A61K33/243 , A61P35/00 , A61K31/277 , C07C255/46 , C07D257/04 , A61K31/41 , A61K31/135 , C07C211/40 , C07D207/335 , A61K31/40 , C07D207/09 , C07D233/64 , A61K31/417 , A61K31/4196 , C07D249/08 , C07D213/38 , A61K31/44 , A61K31/426 , C07D277/28 , C07D487/04 , A61K31/4188 , C07D271/06 , A61K31/165 , C07C233/58 , C07D413/04 , A61K31/4439 , A61K31/437 , C07D471/04 , C07D263/56 , A61K31/423 , A61K31/4375 , C07D217/26 , A61K31/472 , A61K31/451 , C07D211/18 , C07D211/34 , C07D209/44 , A61K31/4035 , A61K31/55 , C07D223/16 , C07D261/20 , A61K31/519 , C07D413/10 , C07D417/04 , A61K31/428 , A61K31/4192 , C07D249/06 , A61K31/4545 , C07D413/14 , A61K31/415 , C07D231/12 , C07D413/06 , A61K31/422
摘要: A cyclopropylamine compound as a lysine-specific demethylase 1 (LSD1) inhibitor. Particularly, the present invention relates to a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. The present invention also provides an application of the same in preparing a drug for treating an LSD1-related disease.
-
-
-
-